8 November 2023
The University of Oxford today announced a partnership with Danaher Corporation to develop a new test to enable precision medicine care for sepsis, a pathological immune response to infection that accounts for one in five deaths globally each year.
26 April 2023
A study by Nuffield Department of Medicine’s Wellcome Centre for Human Genetics, and collaborating researchers have uncovered the genetic signals that cause ankylosing spondylitis, a type of spinal arthritis.
24 April 2023
Researchers from NDM’s Wellcome Centre for Human Genetics and the Queen Mary University have found evidence of how the normally protective response of the immune system to infection can go wrong in sepsis, offering exciting possibilities for the development of more targeted therapies for this deadly condition.
3 March 2022
The COVID-19 Multi-omic Blood Atlas (COMBAT) defines hallmarks of disease severity and specificity
28 February 2022
A team of geneticists and archaeologists have analysed the fine-scale genetic structure and ancestry of nearly 1200 people from the United Arab Emirates (UAE), and found genetic traces of population mixing spanning thousands of years.
7 December 2021
GlaxoSmithKline plc and the University of Oxford today announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
31 August 2021
Endometriosis is a painful, chronic condition in which tissue from the uterus inappropriately grows outside the uterus.
12 May 2021
Dr Eoghan Mulholland has received the prestigious Lee Placito Research Fellowship in Gastrointestinal Cancer. Eoghan will use this 3-year position to research cell interactions in colorectal cancers.
18 January 2021
UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).
20 November 2018
Wellcome Centre for Human Genetics researcher Dr Ross Chapman has been selected as one of the European Molecular Biology Organisation's Young Investigators for 2018.